Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 436

    Becton Dickinson to acquire Bard for 24 billion Dollars

    Becton Dickinson to acquire Bard for 24 billion Dollars

    Ruby Khatun Khatun24 April 2017 12:08 PM IST
    By Carl O'Donnell and Jonathan SpicerNEW YORK: U.S. medical equipment supplier Becton Dickinson and Co will acquire C R Bard Inc, in a $24 billion...
    USFDA issues warning letter to Divis Labs for Vizag unit

    USFDA issues warning letter to Divis Labs for Vizag unit

    Ruby Khatun Khatun24 April 2017 12:04 PM IST
    NEW DELHI: Drug firm Divis Laboratories today said the US health regulator has issued a warning letter to the company for its Visakhapatnam...
    Dr Reddy

    Dr Reddy's launches generic Progesterone capsules in US

    Ruby Khatun Khatun24 April 2017 12:02 PM IST
    New Delhi: Drug firm Dr Reddy's today said it has launched generic Progesterone capsules used in treatment of menstrual irregularities and protection...
    USFDA issues 11 observations for Sun Pharma

    USFDA issues 11 observations for Sun Pharma's Dadra facility

    Ruby Khatun Khatun24 April 2017 12:00 PM IST
    A Form-483 observation letter was issued by the USFDA post the inspection, listing 11 observations.New Delhi: Drug major Sun Pharmaceutical Industries...
    Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

    Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

    Ruby Khatun Khatun23 April 2017 1:38 PM IST
    Patna: Bihar Drug Controller and Bihar police recently raided the godowns of a drug company and seized fake and expired medicines worth over Rs 10...
    AbbVie cancer drug fails two late-stage trials

    AbbVie cancer drug fails two late-stage trials

    supriya kashyap kashyap23 April 2017 12:54 PM IST
    AbbVie Inc said that its experimental cancer drug, veliparib, failed to meet the main goals of two late-stage studies.The trials evaluated the effect...
    Max Bupa collaborates with GOQii, Swiss Re to promote holistic healing

    Max Bupa collaborates with GOQii, Swiss Re to promote holistic healing

    supriya kashyap kashyap23 April 2017 12:45 PM IST
    New Delhi : Health care and insurance expert Max Bupa Health Insurance has announced an exclusive three-way tie up with GOQii, a fitness technology...
    Fight against neglected tropical diseases needs Big Pharma push: WHO

    Fight against neglected tropical diseases needs Big Pharma push: WHO

    supriya kashyap kashyap23 April 2017 11:54 AM IST
    Geneva : Progress has been made in tackling diseases that blind, disable and disfigure millions of poor in tropical areas each year, but drug...
    Narayana Hrudayalaya inks pact with Panacea Biotec

    Narayana Hrudayalaya inks pact with Panacea Biotec

    Ruby Khatun Khatun22 April 2017 12:57 PM IST
    The company has“entered into a definitive agreement to acquire 100 per cent stake in NewRise Healthcare Pvt Ltd from Panacea Biotec Ltd to announce...
    EMA panel recommends nod for Sanofi, Regenerons arthritis drug

    EMA panel recommends nod for Sanofi, Regeneron's arthritis drug

    Ruby Khatun Khatun22 April 2017 12:47 PM IST
    A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat...
    Valeant prices psoriasis treatment at $3,500 per month

    Valeant prices psoriasis treatment at $3,500 per month

    Ruby Khatun Khatun22 April 2017 12:21 PM IST
    Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month,...
    FDA approves Samsung Bioepis copy of J&Js Remicade: company

    FDA approves Samsung Bioepis' copy of J&J's Remicade: company

    Ruby Khatun Khatun22 April 2017 12:20 PM IST
    South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson's rheumatoid...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok